• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

What's Causing Alopecia in Pomeranians?

January 3, 2018
JoAnna Pendergrass, DVM

The exact cause of Alopecia X in Pomeranians remains unknown, but a recent study provided some important genetic clues.

Alopecia is a common canine skin condition. The normal hair growth cycle has 3 main phases: anagen (growth); catagen (regression); and telogen (quiescence); other phases include exogen (hair shedding) and kenogen (empty hair follicles between telogen and anagen).

Follicular epithelial stem cells (SCs) allow for continual epithelial remodeling throughout the hair cycle. The interaction between hair cycle regulation and SC activity is complex and depends on such factors as the dermal microenvironment and molecular signaling pathways like Sonic hedgehog (Shh), bone morphogenic protein (BMP), and Wnt.

Alopecia X (AX) is a hereditary condition that primarily affects Pomeranians and causes truncal alopecia and skin hyperpigmentation. To date, AX’s etiology remains unknown, although altered sex hormone metabolism has been suggested as an underlying cause. A recent PLoS ONE study provided new insight into the molecular basis of canine hair growth and AX.

RELATED

  • A Genetic Mutation Causes a Rare Skin Disease in Dogs
  • New Insight on the Genetic and Neural Basis of Obsessive-Compulsive Disorder

Genetic Analysis

Researchers obtained punch biopsies from the alopecic skin of 5 Pomeranians with AX and haired skin of 4 healthy Pomeranians. Genetic biopsy analyses identified genes and determined gene expression.

AX biopsies revealed hair follicles primarily in telogen or kenogen, suggesting dysfunctional anagen activity. Approximately 1600 genes were identified, with about 570 being upregulated and 1030 being downregulated in the dogs with AX; around 75% of the 1600 genes were involved in either cellular or metabolic processes. Cluster analysis demonstrated separate clusters of alopecic and control samples based on gene expression profiles.

Hair Cycle Regulation

Researchers identified 47 genes responsible for hair cycle regulation. Downregulated genes primarily belonged to the Wnt and Shh pathways, which induce and maintain anagen. For example, the downregulated SHH and SMO genes in the Shh pathway initiate anagen.

Advertisement

Stem Cell Regulation

The Wnt and Shh pathways contained several downregulated genes that normally code for SC markers. A gene that regulates SC quiescence (NFATC1) within the BMP pathway, which inhibits anagen, was upregulated. Future studies are needed to determine whether this downregulation of SC markers indicates specific alopecic conditions or a general response to diseased skin, the researchers noted.

Steroidogenesis, Vitamin D Synthesis, and Melatonin Metabolism

Previous research findings suggest a powerful neuroendocrine system within the skin. In the current study, researchers identified 10 genes responsible for sex hormone synthesis, vitamin D synthesis, and melatonin metabolism.

Estrogen regulates hair follicle biology by inhibiting telogen-to-anagen progression. In this study, up- and down-regulation of genes responsible for estrogen metabolism in the dogs with AX suggest altered estrogen metabolism with this skin condition.

Genes responsible for Vitamin D synthesis and activity were markedly downregulated in dogs with AX. Because Vitamin D is important for estradiol biosynthesis, such downregulation can ultimately alter estrogen metabolism.

Genes involved in degrading melatonin (CYP1A1, CYP1B1), which the skin produces and metabolizes, were upregulated in dogs with AX. Melatonin treatment can partially reverse this degradation.

Notably, the KISS1 gene, which regulates gonadotropin-releasing hormone (GnRH) release, was downregulated in dogs with AX; lowered GnRH release can alter sex hormone metabolism via the hypothalamic-pituitary-adrenal axis. Previous studies have reported hair regrowth after treatment with the GnRH analogue deslorelin in Pomeranians with AX. Interestingly, melatonin treatment stimulates hair regrowth despite downregulating GnRH release. Such findings underscore the complexity of hair cycle regulation in AX.

Bringing it Together

The study’s findings provide novel molecular insights into canine hair growth and AX, the researchers concluded. Study results also lend strong support to the hypothesis that altered sex hormone metabolism in the skin plays a role in AX development in Pomeranians.

Because of the skin’s neuroendocrine system, the researchers advised that measuring plasma hormone levels may not be appropriate when diagnosing AX.

Dr. JoAnna Pendergrass received her Doctor of Veterinary Medicine degree from the Virginia-Maryland College of Veterinary Medicine. Following veterinary school, she completed a postdoctoral fellowship at Emory University’s Yerkes National Primate Research Center. Dr. Pendergrass is the founder and owner of JPen Communications, a medical communications company.


Advertisement

Latest News

AAHA Con heads to San Diego

VHMA announces latest class of CVPMs

Jaguar undergoes anesthesia to determine cause of appetite loss

New online course for veterinary business at UC Davis

View More Latest News
Advertisement